Dr. Christopher N. Mores | |
---|---|
Education | Rutgers University (BS) Harvard University (SM) Harvard University (ScD) |
Scientific career | |
Fields | Vector-borne disease Zoonotic disease Vaccinology Infectious disease Global health Immunology Virology |
Institutions | Milken Institute School of Public Health |
Website | GW website |
Christopher Mores is an American (US) arbovirologist, trained in infectious disease epidemiology. [1] He is a professor in the Department of Global Health at the Milken Institute School of Public Health, the program director for the Global Health Epidemiology and Disease Control MPH program, and is director of a high-containment research laboratory at the George Washington University in Washington, DC.
Mores first gained an interest in infectious disease after taking a microbiology course taught by Dr. Douglas Eveleigh while earning his Bachelor of Science degree in biological sciences from Rutgers University in 1995. [2] He then went on to receive his Master of Science in Tropical Public Health from Harvard University in 1998, and his Doctor of Science in Immunology and Infectious Diseases under Dr. Andrew Spielman from Harvard University in 2002. During these years he worked at the Massachusetts Department of Health on Arboviral and Zoonotic Disease Surveillance where he developed a program for biological threat testing and emergency response. He then completed postdoctoral training in vector-borne and viral hemorrhagic fever viruses as a National Research Council Fellow at United States Army Medical Research Institute of Infectious Diseases. [3]
Following his postdoctoral training, in 2004 Mores became an assistant professor at the University of Florida Medical Entomology Laboratory. While there, he worked to improve public health capacity, research arboviruses, and build arbovirus surveillance programs in Central Asia in collaboration with the US Department of Defense. [4]
In 2007, he became assistant professor at Louisiana State University (LSU), and was later promoted to associate professor in 2010, and then to professor in 2015. At LSU, he also led laboratories researching pathogen emergence, was the associate director of the Center for Experimental Infectious Disease Research, and the director of the high-containment laboratory at the LSU School of Veterinary Medicine. [5] There he researched the transmission systems of dengue, Zika, and chikungunya viruses, led a consortium of mathematical modelers to develop novel predictive tools, and investigated numerous outbreaks. This included serving as the lead epidemiologist, biocontainment specialist, and infection control officer for the Irish NGO GOAL Aid Agency during the 2014-2015 West African Ebola outbreak in Sierra Leone. While there, he developed and deployed biocontainment strategies to mitigate the outbreak, both in the community and at the Ebola Treatment Center in Port Loko. [6]
Upon his return form Sierra Leone, Mores accepted the head of the Virology and Emerging Infections Department at the Naval Medical Research Unit Six in Peru. During this time, he investigated the initial Zika virus outbreak in the Americas and managed programs and acute febrile illness, influenza surveillance, community-acquired gastroenteritis, and diagnostic platform development using pathogen discovery (NGS) techniques. [7]
Currently, he is a professor in the Department of Global Health at the Milken Institute School of Public Health at the George Washington University in Washington, D.C., where he is also the director of a high-containment research laboratory. [3] He continues to work closely with the US government and industry on countermeasures to emerging infectious disease threats. [8] Most of his time at GW has focused on work relating to the COVID-19 pandemic, including testing the effectiveness of vaccine candidates as well as diagnostic and antibody tests. [2] He has participated in over 250 live TV, radio, and print media interviews related to the SARS-CoV-2 outbreak. [9] [10] Despite the pandemic, he continued to work with the US CDC and the Institut National pour la Recherche Biomedicale on Ebola outbreak response in the Democratic Republic of Congo. There he supported local and international field teams and developed programs to improve laboratory capacity. [11] [12] [13] Mores also holds an adjunct professorship at Tulane University.
Mores has over 100 peer reviewed publications [14] and is a Fellow of American Society of Tropical Medicine & Hygiene (FASTMH). [15] He is an active member of American Society of Tropical Medicine & Hygiene (ASTMH), American Committee on Arthropod-borne Viruses, American Committee on Medical Entomology, American Committee on Global Health and American Society for Virology. [5]
Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents include bacteria, viruses, insects, fungi, and/or toxins, and may be in a naturally occurring or a human-modified form, in much the same way as in biological warfare. Further, modern agribusiness is vulnerable to anti-agricultural attacks by terrorists, and such attacks can seriously damage economy as well as consumer confidence. The latter destructive activity is called agrobioterrorism and is a subtype of agro-terrorism.
A biosafety level (BSL), or pathogen/protection level, is a set of biocontainment precautions required to isolate dangerous biological agents in an enclosed laboratory facility. The levels of containment range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4). In the United States, the Centers for Disease Control and Prevention (CDC) have specified these levels in a publication referred to as BMBL. In the European Union, the same biosafety levels are defined in a directive. In Canada the four levels are known as Containment Levels. Facilities with these designations are also sometimes given as P1 through P4, as in the term P3 laboratory.
The National Microbiology Laboratory (NML) is part of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.
One use of the concept of biocontainment is related to laboratory biosafety and pertains to microbiology laboratories in which the physical containment of pathogenic organisms or agents is required, usually by isolation in environmentally and biologically secure cabinets or rooms, to prevent accidental infection of workers or release into the surrounding community during scientific research.
The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
The Aeromedical Isolation Team of the US Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland was a military rapid response team with worldwide airlift capability designed to safely evacuate and manage contagious patients under high-level (BSL-4) bio-containment conditions. Created in 1978, during its final years the AIT was one of MEDCOM’s Special Medical Augmentation Response Teams comprising a portable containment laboratory along with its transit isolators for patient transport. Contingency missions included bioterrorism scenarios as well as the extraction of scientists with exotic infections from remote sites in foreign countries. The AIT trained continuously and was often put on alert status, but only deployed for “real world” missions four times. The AIT was decommissioned in 2010 and its mission was assumed by one of the US Air Force’s Critical Care Air Transport Teams (CCATTs).
Robert Ellis Shope was an American virologist, epidemiologist and public health expert, particularly known for his work on arthropod-borne viruses and emerging infectious diseases. He discovered more novel viruses than any person previously, including members of the Arenavirus, Hantavirus, Lyssavirus and Orbivirus genera of RNA viruses. He researched significant human diseases, including dengue, Lassa fever, Rift Valley fever, yellow fever, viral hemorrhagic fevers and Lyme disease. He had an encyclopedic knowledge of viruses, and curated a global reference collection of over 5,000 viral strains. He was the lead author of a groundbreaking report on the threat posed by emerging infectious diseases, and also advised on climate change and bioterrorism.
John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.
Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen. Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses, instead of just individual strains, thus improving WHO capability to respond to unforeseen strains. In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X.
Jean-Paul Joseph Gonzalez is a French virologist. He graduated from the Medical School of Bordeaux University France.
Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.
Syra Madad is an American pathogen preparedness expert and infectious disease epidemiologist. Madad is the Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals where she is part of the executive leadership team which oversees New York City's response to the Coronavirus disease 2019 pandemic in the city's 11 public hospitals. She was featured in the Netflix documentary series Pandemic: How to Prevent an Outbreak and the Discovery Channel documentary The Vaccine: Conquering COVID.
Michael Joseph Ryan is an Irish epidemiologist and former trauma surgeon, specialising in infectious disease and public health. He is executive director of the World Health Organization's Health Emergencies Programme, leading the team responsible for the international containment and treatment of COVID-19. Ryan has held leadership positions and has worked on various outbreak response teams in the field to eradicate the spread of diseases including bacillary dysentery, cholera, Crimean–Congo hemorrhagic fever, Ebola, Marburg virus disease, measles, meningitis, relapsing fever, Rift Valley fever, SARS, and Shigellosis.
Nahid Bhadelia is an American infectious-diseases physician, founding director of Center for Emerging Infectious Diseases Policy and Research (CEID), an associate director at National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University, and an associate professor at the Boston University School of Medicine. She currently serves as the Senior Policy Advisor for Global COVID-19 Response on the White House COVID-19 Response Team.
Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.
Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.
Science diplomacy is the collaborative efforts by local and global entities to solve global issues using science and technology as a base. In science diplomacy, collaboration takes place to advance science but science can also be used to facilitate diplomatic relations. This allows even conflicting nations to come together through science to find solutions to global issues. Global organizations, researchers, public health officials, countries, government officials, and clinicians have previously worked together to create effective measures of infection control and subsequent treatment. They continue to do so through sharing of resources, research data, ideas, and by putting into effect laws and regulations that can further advance scientific research. Without the collaborative efforts of such entities, the world would not have the vaccines and treatments we now possess for diseases that were once considered deadly such as tuberculosis, tetanus, polio, influenza, etc. Historically, science diplomacy has proved successful in diseases such as SARS, Ebola, Zika and continues to be relevant during the COVID-19 pandemic today.
Jordi Casals i Ariet was a Catalan physician and epidemiologist.